Citadel Advisors - ONCOLYTICS BIOTECH INC ownership

ONCOLYTICS BIOTECH INC's ticker is ONCY and the CUSIP is 682310875. A total of 35 filers reported holding ONCOLYTICS BIOTECH INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ONCOLYTICS BIOTECH INC
ValueSharesWeighting
Q1 2023$105,429
+73.5%
87,858
+135.7%
0.00%
Q4 2022$60,752
+237.5%
37,271
+220.2%
0.00%
Q1 2022$18,000
-86.5%
11,639
-87.8%
0.00%
Q4 2021$133,000
+269.4%
95,335
+461.2%
0.00%
Q3 2021$36,000
-55.6%
16,988
-42.2%
0.00%
Q2 2021$81,000
-56.9%
29,389
-40.5%
0.00%
Q1 2021$188,000
+382.1%
49,378
+113.4%
0.00%
Q3 2020$39,000
-45.8%
23,139
-39.2%
0.00%
Q2 2020$72,000
-53.2%
38,036
+17.2%
0.00%
Q4 2019$154,000
+1440.0%
32,465
+91.9%
0.00%
Q3 2019$10,000
-81.5%
16,916
-42.7%
0.00%
Q1 2019$54,00029,5200.00%
Other shareholders
ONCOLYTICS BIOTECH INC shareholders Q2 2020
NameSharesValueWeighting ↓
Verition Fund Management LLC 408,838$695,0000.02%
Magnus Financial Group LLC 10,000$17,0000.00%
SCOTIA CAPITAL INC. 48,039$83,0000.00%
HUNTINGTON NATIONAL BANK 1,052$2,0000.00%
BANK OF AMERICA CORP /DE/ 367$1,0000.00%
WELLS FARGO & COMPANY/MN 642$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
HOWE & RUSLING INC 105$00.00%
1832 Asset Management L.P. 5$00.00%
DEUTSCHE BANK AG\ 4,601$7,0000.00%
View complete list of ONCOLYTICS BIOTECH INC shareholders